V.I. Dzyuba et al. / Polyhedron 180 (2020) 114421
3
2.3.3. Chloro-oxo-bis(N-methylbenzohydroxamato)vanadium(V) (3)
Complex 3 was prepared by method 1, taking N-methylbenzo-
hydroxamic acid (10 mmol, 1.51 g) in dry chloroform as a basis,
and purified by crystallization from a chloroform/hexane mixture
(1/8) at 5 °C. Yield: 1.57 g, 78%. Anal. Found: C, 47.31; H, 3.92; N,
6.76. Calc. for C16H16N2O5ClV (MW 402.71): C, 47.72; H, 4.01; N,
The elemental analysis was carried out on a Carlo Erba 1106 ana-
lyzer. The 1H and 51V NMR spectra were recorded on a BRUKER
AVANCE 400 spectrometer in CDCl3 and CH3CN solutions with
internal TMS and external VOCl3 standards.
2.5. X-ray crystallography
6.96%. UV/Vis: kmax(CHCl3)/nm (
e
/dm3 molꢀ1 cmꢀ1): 514 (4072).
IR (KBr)
m
max/cmꢀ1: 3064 (w), 3030 (w), 2930 (w, br), 1590 (s),
The structure of compound 5 was determined by X-ray crystal-
1570 (m), 1540 (m), 1496 (s), 1455 (vs), 1425 (vs), 1380 (s),
1313 (w), 1281 (w), 1229 (s), 1185 (s), 1066 (s), 1023 (m), 1000
(w), 965 (vs), 830 (w, br), 777 (s), 735 (s), 692 (s), 655 (s), 620
(m), 577 (s), 550 (m), 512 (w), 494 (w), 446 (s), 417 (w), 404 (w).
1H NMR (400 MHz, CDCl3, 25 °C, TMS), d, ppm: 7.59 (m, 5H,
C6H5), 3.77 (s, 3H, N-CH3). 51V NMR (105.2 MHz, CDCl3, 25 °C,
VOCl3), d, ppm: ꢀ283.7, ꢀ297.3; (ꢀ274.7, ꢀ288.0, CH3CN).
Complex 3 was also prepared by method 2 using Cu(N-MBH)2
(2.5 mmol, 0.91 g) and was purified by crystallization. Yield:
0.71 g, 71%. The compound was identified by comparing IR spectra
of samples prepared by methods 1 and 2.
lography. Suitable deep violet single crystals were formed by crys-
tallization from
a chloroform/ hexane mixture, obtained by
interdiffusion of solvents through the gaseous state in a closed
space. The single crystal X-ray diffraction data collection for the
complex was performed on a BRUKER SMART APEX-II CCD diffrac-
tometer, using Mo K
a radiation with a graphite monochromator
(k = 0.71073 Å) at 205 K. Reflection intensities were integrated
using SAINT software [20] and corrected for absorption by multi-
scan absorption corrections using SADABS [21]. The structure
was solved by the direct method and refined against F2 by the
full-matrix least-squares method using the SHELXTL package
[22]. Positions of the hydrogen atoms were located from electron
density difference maps and refined by the ‘‘riding” model with
Uiso = nUeq of the carrier atom (n = 1.5 for methyl groups and
n = 1.2 for other hydrogen atoms). Crystal data for C8H14Cl7N2O5V
(M = 517.30 g/mol): monoclinic, space group P21 (no. 4), a = 8.2670
2.3.4. Chloro-oxo-bis(N-methyldecanohydroxamato)vanadium(V) (4)
Complex 4 was prepared by method 1, taking N-methylde-
canohydroxamic acid (10 mmol, 2.01 g) in dry toluene as a basis,
and purified by crystallization from a toluene/hexane mixture
(1/5) at ꢀ12 °C. Yield: 1.81 g, 72%. Anal. Found: C, 52.31; H, 9.02;
N, 5.76. Calc. for C22H44N2O5ClV (MW 502.99): C, 52.53; H, 8.82;
(2) Å, b = 13.8107(4) Å, c = 8.6884(2) Å,
a
= 90.00°, b = 98.3290
= 90.00°. V = 981.52(4) Å3, Z = 2, T = 205 K,
) = 1.477 mmꢀ1, Dcalc = 1.750 g/cm3, 23,128 reflections mea-
62.76°), 6393 unique (Rint 0.0302,
(10)°,
c
l
N, 5.57%. UV/Vis kmax(CHCl3)/nm
(e
/dm3 molꢀ1 cmꢀ1): 514
(MoKa
(3955). IR (KBr)
m
max/cmꢀ1: 2935 (m), 2860 (m), 1594 (s), 1560
sured (4.74°
ꢂ
2
H
ꢂ
=
(m), 1457 (s, br), 1392 (m), 1373 (w), 1330 (w, br), 1212 (m, br),
1144 (m), 1103 (m, br), 1060 (w), 1044 (w), 970 (vs), 810 (m),
772 (w, br), 730 (m br), 685 (w, br), 655 (m), 625 (m), 588 (m),
540 (w), 530 (w), 497 (m), 484 (w), 475 (w), 464 (w), 455 (w),
420 (m). 1H NMR (400 MHz, CDCl3, 25 °C, TMS), d, ppm: 3.64 (s,
Rsigma = 0.0274) which were used in all calculations. The final R1
value was 0.0332 (>2sigma(I)) and wR2 was 0.0859 (all data).
3. Results and discussion
3H, N-CH3) 2.42 (m, 2H, b-CH2), 1.67 (m, 2H, c-CH2), 1.26 (m,
3
12H, (CH2)6), 0.88 (t, JH–H
=
6.9 Hz, 3H, CH3). 51V NMR
3.1. Synthesis
(105.2 MHz, CDCl3, 25 °C, VOCl3), d, ppm: ꢀ282.5, ꢀ297.0;
(ꢀ270.5, ꢀ285.5, CH3CN).
The overwhelming majority of publications dealing with metal
and metalloid hydroxamato complexes relate to chemical biology
and medicinal chemistry [23]. The pharmaceutical industry
remains completely dependent on the development of synthetic
chemistry methods for the preparation of compounds for new
medicaments [24,25]. One of the key indicators of the possible
implementation of synthesis methods in industry is the availability
of affordable and high-quality raw materials. Multi-megawatt all-
vanadium redox flow battery (VRFB) systems for large-scale energy
storage have been demonstrated worldwide. The electrolyte of
these huge batteries is an aqueous sulfate solution of high-purity
vanadium pentoxide, the intermediate product of which is vana-
dium oxytrichloride, of appropriate purity [26]. This low-cost,
large-tonnage, high-purity product as a precursor opens up broad
prospects for the applied chemistry of chloro-oxo-bis(hydroxam-
ato)vanadium(V) complexes. On the other hand, the preparative
method for the synthesis of vanadium oxytrichloride from vana-
dium pentoxide and thionyl chloride [15] turned out to be accept-
able after minor modifications. A small stoichiometric excess of
V2O5 allows the separation of VOCl3 from the reaction mass by
simple distillation, without first distilling off the excess SOCl2.
The application of fluorinated grease on the ground glass joints
allows the reuse of the same reactor. It should be noted that VOCl3
is extremely easily hydrolyzed and, for example, all syntheses with
bidentate dicarbonyl proligands were carried out in rigorously
dried glassware using freshly dried proligands and solvents [27].
An attempt to adapt the method used to obtain bis(hydroxam-
ato)-dioxo-molybdenum(VI) complexes from MoO2Cl2 [16] for
the synthesis of chloro-oxo-bis(hydroxamato)vanadium(V) com-
plexes involved considerable difficulties. Vanadium oxytrichloride
Complex 4 was also prepared by method 2 using Cu(N–MDH)2
(2.5 mmol, 1.16 g) and was purified by crystallization. Yield:
1.02 g, 81%. The compound was identified by comparing IR spectra
of samples prepared by methods 1 and 2.
2.3.5. Chloro-oxo-bis(N-methylacetohydroxamato)vanadium(V) (5)
Complex 5 was prepared by method 1, taking N-methylacetohy-
droxamic acid (10 mmol, 0.89 g) in dry chloroform as a basis, and
purified by crystallization from a chloroform/hexane mixture (1/1)
at 5 °C. Yield: 0.89 g, 64%. Anal. Found: C, 25.16; H, 4.84; N, 10.65.
Calc. for C6H12N2O5ClV (MW 278.55): C, 25.87; H, 4.34; N, 10.05%.
UV/Vis kmax(CHCl3)/nm (
m
e
/dm3 molꢀ1 cmꢀ1): 514 (2075). IR (KBr)
max/cmꢀ1: 3029 (m), 3010 (m), 2947 (w), 1619 (s), 1556 (s),
1458 (vs), 1444 (vs), 1397 (vs), 1366 (m), 1225 (s), 1208 (s),
1168 (s), 1030 (m), 1009 (m), 994 (m), 965 (vs), 755 (vs), 669
(m), 633 (s), 592 (s), 545 (w), 524 (m), 501 (m), 465 (w), 420 (s).
1H NMR (400 MHz, CDCl3, 25 °C, TMS), d, ppm: 3.77 (s, 3H, N-
CH3), 2.43 (s, 3H, CH3). 51V NMR (105.2 MHz, CDCl3, 25 °C, VOCl3),
d, ppm: ꢀ 280.8, ꢀ 297.6; (ꢀ270.6, ꢀ286.8, CH3CN).
Complex 5 was also prepared by method 3. Yield: 1.01 g, 65%.
The compound was identified by comparing IR spectra of samples
prepared by methods 1 and 3.
2.4. Physical measurements
The IR spectra were recorded in KBr pellets in the range 4000–
400 cmꢀ1 on a Specord M80 spectrophotometer and electronic
spectra on a Specord M40 spectrophotometer, both of which were
equipped with an IBM-compatible operating computing system.